The renin-angiotensin-aldosterone system (RAAS) is a hormone signaling pathway responsible for regulating the body’s blood pressure, fluid, and electrolyte levels.
Renin-angiotensin-aldosterone system (RAAS)
Index
- ACE inhibitor
- ACTH
- Adenoma
- Adrenal gland
- Adrenal Venous Sampling (AVS)
- Adrenalectomy
- Adrenocortical carcinoma
- Aldosterone
- Aldosterone synthase inhibitors
- Aldosterone-producing adenoma
- Aldosteronoma
- Amiloride
- Angiotensin receptor blocker (ARB)
- Atrial fibrilation
- Calcium channel blocker
- Cardiologist
- Cardiovascular
- Conn’s Syndrome
- Cortisol
- Cosyntropin
- CT scan
- Cushing’s Syndrome
- DASH diet
- Diabetes mellitus
- Diuretic
- Echocardiogram
- Ectopic tumor
- Edema
- Electrocardiogram (EKG or ECG)
- Endocrinologist
- Hypernatremia
- Hypokalemia
- Incidentaloma
- Inferior Vena Cava
- Interventional radiologist
- Left Ventricular Hypertrophy (LVH)
- Mineralocorticoid receptor antagonist (MRA)
- Myocardial infarction
- Nephrologist
- Renin
- Renin-angiotensin-aldosterone system (RAAS)
- Secondary aldosteronism
- Secondary hypertension
- Sensitivity
- Sleep apnea
- Specificity
- MedTerms Medical Dictionary
- Harvard Health Medical Dictionary
- Mayo Clinic Diseases and Conditions
- Funder, J. W., Carey, R. M., Mantero, F., Murad, M. H., Reincke, M., Shibata, H., Stowasser, M., & Young Jr, W. F. (2016). The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 101(5), 1889-1916.
- Young Jr, W. F. (2019). Diagnosis and treatment of primary aldosteronism: practical clinical perspectives. The Journal of Internal Medicine, 285(2), 126-148.
